Latest Stroke recovery Stories
Hand Mentorâ„¢ and Foot Mentorâ„¢ therapy robots from Kinetic Muscles, Inc., an innovator of stroke rehabilitation therapies, will be featured at the TechnoPolooza event by the American Physical Therapy Association (APTA). (Vocus/PRWEB) February 10, 2011 Hand Mentorâ„¢ and Foot Mentorâ„¢ therapy robots from Kinetic Muscles, Inc.
Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStemÂ®, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.
Therapy in which robots manipulate paralyzed arms, combined with standard rehabilitation, can improve arm and shoulder mobility in patients after stroke.
Kinetic Muscles, Inc., an innovator of stroke rehabilitation therapies, and Great Wall Medical Holdings, Ltd (â€œGWMHâ€) announced they will collaborate to deploy products based on Kinetic Musclesâ€™ leading neurotherapy technologies to the burgeoning Chinese healthcare market. Tempe, AZ (Vocus/PRWEB) January 16, 2011 Kinetic Muscles, Inc.
Stroke is the leading cause of adult disability, due to the brain's limited capacity for recovery.
MOUNTAIN VIEW, Calif., Oct. 4 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd. (DSP) and SanBio, Inc. (SanBio) today announced that they have entered into an option agreement to co-develop a new cell therapy for stroke recovery. Under the agreement, DSP has received an option for exclusive U.S.
Acupuncture is a new growing trend among healthcare treatments.
Music therapy provided by trained music therapists may help to improve movement in stroke patients.
MOUNTAIN VIEW, Calif., June 28 /PRNewswire/ -- New avenues are unfolding for companies engaged in leveraging medical technologies to unleash devices that target debilitating neurological disorders.
MOUNTAIN VIEW, Calif., June 16 /PRNewswire/ -- SanBio Inc. (www.san-bio.com) announced today that the United States Food and Drug Administration (FDA) has approved the clinical testing of their SB623 regenerative medicine product in patients suffering from disability caused by cerebral stroke.
- The abrogation of a law by a higher authority; annulment.